Adams Street Partners’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34,157
Closed -$331K 17
2022
Q3
$331K Hold
34,157
0.09% 13
2022
Q2
$470K Hold
34,157
0.12% 14
2022
Q1
$803K Buy
+34,157
New +$969K 0.15% 13
2021
Q2
Sell
-160,626
Closed -$7.51M 25
2021
Q1
$7.51M Sell
160,626
-40,922
-20% -$1.98M 1.2% 12
2020
Q4
$8.77M Hold
201,548
1.82% 7
2020
Q3
$6.64M Buy
+201,548
New +$6.84M 1.75% 7

Other funds holding HCAT

Adams Street Partners's HCAT Position: Q4 2022 in Review

Adams Street Partners sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 34,157 shares — an estimated $331K sold.

Adams Street Partners first reported a position in HCAT in Q3 2020 and held it in 6 quarters. The position peaked at $8.77M in Q4 2020. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

  • Adams Street Partners reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
  • Adams Street Partners sold 34,157 Health Catalyst shares in Q4 2022, an estimated $331K.
  • Adams Street Partners first reported a position in Health Catalyst in Q3 2020 and held it in 6 quarters.
  • Adams Street Partners's Health Catalyst position peaked at $8.77M in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on Adams Street Partners's 13F filing for Q4 2022, filed 15 Feb 2023.